| You are here: Home: BCU 9|2004: Kathy D Miller, MD: Select publications
Select publications
Albain KS et al. Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as
frontline therapy for metastatic breast cancer (MBC): First report of overall survival. J Clin Oncol 2004;22(14 Suppl);Abstract 510.
Baum M et al; The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists’ Group. Anastrozole
alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of
postmenopausal women with early-stage breast cancer: Results of the ATAC (Arimidex, Tamoxifen
Alone or in Combination) trial efficacy and safety update analyses. Cancer 2003;98(9):1802-10.
Abstract
Baum M et al; The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists’ Group. Anastrozole
alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of
postmenopausal women with early breast cancer: First results of the ATAC randomised trial. The Lancet 2002;359(9324):2131-9. Abstract
Coombes RC et al. A randomized trial of exemestane after two to three years of tamoxifen therapy
in postmenopausal women with primary breast cancer. N Engl J Med 2004;350(11):1081-92.
Abstract
Goss PE et al. A randomized trial of letrozole in postmenopausal women after five years of
tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349(19):1793-802. Abstract
Hurwitz H et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic
colorectal cancer. N Engl J Med 2004;350(23):2335-42. Abstract
Miller KD et al. Phase III trial of capecitabine (Xeloda®) plus bevacizumab (Avastin™) versus
capecitabine alone in women with metastatic breast cancer (MBC) previously treated with an
anthracycline and a taxane. Breast Cancer Res Treat 2002;76(Suppl 1);Abstract 36.
O’Shaughnessy J et al. Superior survival with capecitabine plus docetaxel combination therapy in
anthracycline-pretreated patients with advanced breast cancer: Phase III trial results. J Clin Oncol 2002;20(12):2812-23. Abstract
Paik S et al. Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer
patients — NSABP studies B-20 and B-14. Breast Cancer Res Treat 2003;82(Suppl 1):10;Abstract 16.
|
